Quebec Gold-Silver Developer Advances Montauban Commissioning
Source: Streetwise Reports 09/11/2026
ESGold advances Montauban commissioning after Falcon concentrator arrival at its 1000 tpd facility in Quebec. First gold production targeted for late 2026 with drilling underway.
ESGold Corp. (ESAU:CSE; ESAUF:OTCQB; Z7D:FSE) is moving its fully permitted Montauban gold-silver project in Quebec closer to production after key equipment reached the site, according to a recent press release.
The arrival of a Falcon gravity concentrator and industrial thickeners marks a clear step forward for the 1,000-tonne-per-day processing facility.
Key Investor Takeaways
- ESGold is advancing commissioning at its fully permitted Montauban gold-silver project in Quebec.
- New equipment, including a Falcon gravity concentrator and industrial thickeners, has arrived at the processing facility.
- Montauban’s processing facility is designed to handle up to 1,000 tonnes of material per day.
- The company expects first gold production to take place in late 2026, with its 2026 surface diamond drilling program now underway.
- Atrium Research maintains a Buy rating and CA$1.30 price target for ESGold.
Retail investors often watch equipment deliveries at pre-production projects because they signal the shift from construction to operational testing. At Montauban, the new components will now enter installation, integration, and testing phases.
Why Commissioning Progress Matters Now
Gold prices have remained well above levels seen in 2025 even after recent volatility. Gold.org noted that catalysts such as lower interest-rate expectations could support further upside. This environment gives permitted projects like Montauban a clearer path to cash flow once processing begins.
Brian Taylor of Recycling Today said the World Bank expects its metals and minerals price index to rise 17 percent in 2026. Higher prices improve margins for low-cost operations that reprocess tailings rather than mine new ore.
Company Advantages at Montauban
Montauban stands out because it is already fully permitted and funded. The project will reprocess legacy tailings across five sites using a 1,000-tonne-per-day mill. Tailings reprocessing removes the need for drilling and blasting, keeping operating costs near CA$35 per tonne and supporting forecast margins around 72 percent.
The main mill building is complete. Additional processing components continue to arrive as the company assembles the full circuit that includes grinding, separation, cyanide leaching, Merrill-Crowe recovery, and doré production.
Key Assets and Next Catalysts
The Falcon gravity concentrator uses centrifugal force to recover fine precious metals. Industrial thickeners will help manage slurry density and recycle water within the circuit. Both items are now on site and moving through the commissioning sequence.
ESGold’s 2026 surface diamond drilling program is already underway. The commencement of its 2026 surface diamond drilling program was described by analysts as a critical milestone. Exploration and expansion work is expected to continue into 2027, with Atrium Research noting that future discoveries could potentially provide additional production feed without requiring additional mill capital.
The company’s investor presentation highlights construction updates and throughput results as near-term focus areas. First gold production remains targeted for late 2026. [OWNERSHIP_CHART-2969]
Analyst Views and Valuation Context
Atrium Research reiterated its Buy rating and CA$1.30 price target after the drilling announcement. The analyst noted that ESGold trades at roughly 0.4 times net asset value and 3.0 times 2027 estimated cash flow, compared with peer averages of 0.6 times NAV and 5.3 times price-to-cash-flow. This discount could narrow as production nears.
Share Structure and Near-Term Events1
ESGold has a market capitalization of CA$63.82 million and 110.21 million shares outstanding. The 52-week range is CA$0.42 to CA$1.08. Institutions hold 5 percent, management and insiders hold 60 percent, and retail investors hold the remaining 35 percent.
Commissioning is a staged process of installing, connecting, and testing equipment so a plant can move toward steady operation. Investors should monitor further equipment integration updates and initial throughput results over the coming quarters.
Common Questions from Investors
Q: What is the current status of Montauban?
A: The project is fully permitted and in the commissioning phase after new processing equipment arrived on site.
Q: When is the first gold production expected?
A: ESGold targets late 2026 for first gold production, subject to continued commissioning progress.
Q: What makes Montauban lower risk than typical exploration projects?
A: It reprocesses existing tailings rather than mining new ore, which lowers operating costs and avoids drilling and blasting.
Q: What rating does the covering analyst maintain?
A: Atrium Research maintains a Buy rating with a CA$1.30 price target.
ESGold continues to execute on its permitted timeline while gold market conditions remain supportive for near-term producers.
Sign up for our FREE newsletter at: www.streetwisereports.com/get-news
Important Disclosures:
- ESGold Corp. is a billboard sponsor of Streetwise Reports. The company pays a monthly sponsorship fee of US$3,000–US$6,000 for banner advertising and an enhanced company profile page. Streetwise Reports’ editorial content is fully independent and is not influenced by sponsorship.
- Jordan Nova wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
1. Ownership and Share Structure Information
The information listed above was updated on the date this article was published and was compiled from information from the company and various other data providers.
( Companies Mentioned: ESAU:CSE;ESAUF:OTCQB; Z7D:FSE, )
Source: https://www.streetwisereports.com/article/2026/09/11/quebec-gold-silver-developer-advances-montauban-commissioning.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

